Exploring ethical implications, value assessment, & reimbursement strategies for gene therapy. Funded by @ELSIhub. Co-led by @hadleyssmith & @Meghan_Halley
We are excited to launch a new @ELSIhub-funded working group to explore patient-centered & ethically informed approaches to #value assessment & reimbursement of #GeneTherapy! We will share relevant research and info about our activities here. #EconGenomics
#FDA Meeting 2: Patient and Care Partner Perspectives on Early Enrollment into Gene Therapy Clinical Trials for Rare Diseases fda.gov/news-events/meeting-…
If you are a scientist, clinician, economist, ethicist, patient/caregiver, etc. who wants to know more about HTA or reimbursement for gene therapies, this is a fantastic opportunity to hear from @tenHamR and @brootmcq, whose research is actively shaping policy. Join us!
While the promise of a 1-time treatment has prompted justifiable excitement, the upfront cost of these #gene therapies raises complex ethical & policy issues.
Hear from co-PIs @hadleyssmith & @Meghan_Halley about the new Value #Ethics CERA Working Group! elsihub.org/news/value-ethic…
Please welcome our new CERA Working Group, "Value Ethics: Mapping Strategies for Value Assessment and Reimbursement of #Gene Therapies for Rare Disease," co-led by @hadleyssmith & @Meghan_Halley. Learn about the goals & members of the working group here: elsihub.org/working-group/20…
ALT Light blue background with lighter blue image of gears, one gear containing a dollar sign. Text on image in darker blues: Value Ethics working group: Ethics, value assessment, & reimbursement of gene therapy.
Our annual symposium "Emerging Therapies for Orphan Diseases: Ethics and Economics" is in 2 weeks! Hear how patient orgs, clinicians, INESSS, and health economists think about pricey meds & rare diseases. Sim. translation in fr/eng. More info/reg here: mcgill.ca/biomedicalethicsun…
This is a much more readable & compelling version of the lecture I’ve been giving for the last 3 years. If you work in drug development, please read it
UCalgary researchers including @GEECSEcon & @UCSF_TRANSPERS collaborator Deborah Marshall lead international program to develop value framework on socioeconomic impact of living with rare disease news.ucalgary.ca/news/ucalga…